Jean‐Claude Barbare

Author

Jean‐Claude Barbare

Also Known As

Barbare, Jean-Claude, J. Barbare, J. C. Barbare, J.-C. Barbare, J.C. Barbare, Jean-Claude Barbare, Jean‐Claude Barbare, Jean‑Claude Barbare, R.E. Poupon

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire Amiens-Picardie Université de Picardie Jules Verne Centre Hospitalier Universitaire de Reims Université de Reims Champagne-Ardenne

About

Jean‐Claude Barbare is an author at Inserm specializing in medicine, hepatocellular carcinoma, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1K
2	Cell Biology	4	4	609
3	Health Sciences	1	1	67
4	Public Health	1	1	23
5	Epidemiology	1	1	23

Jean‐Claude Barbare

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib Christophe Louandre, Zakaria Ezzoukhry, Corinne Godin, International Journal of Cancer	2013	582
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells Christophe Louandre, Ingrid Marcq, Hicham Bouhlal, Cancer Letters Cancer ResearchMedicineLiver PhysiologyPathologyLiver Cancer	2014	370
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib Zakaria Ezzoukhry, Christophe Louandre, E. Trécherel, International Journal of Cancer Egfr ActivationImmunologyHepatocellular Carcinoma CellsPathologyHcc Proliferation	2012	167
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib Aline Houessinon, Catherine Franois, Chloé Sauzay, Molecular Cancer	2016	145
Randomized Controlled Trial of Tamoxifen in Advanced Hepatocellular Carcinoma Jean‐Claude Barbare, Olivier Bouché, Franck Bonnetain, Journal of Clinical Oncology	2005	131
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials Sandra Collette, Franck Bonnetain, Xavier Paolettí, Annals of Oncology HepatologyFrench Clinical TrialsMedicineHistopathologyPathology	2008	82
Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial Jean–Claude Trinchet, Beverley Balkau, Renée E. Poupon, Hepatology	1992	76
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma Momar Diouf, Thomas Filleron, Jean‐Claude Barbare, Journal of Hepatology Palliative CareQuality Of LifeLife AssessmentPalliative Hepatocellular CarcinomaHepatology	2012	67
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study Jean‐Claude Barbare, Olivier Bouché, Franck Bonnetain, European Journal of Cancer Long-acting OctreotideHepatologyMedicinePathologyPlacebo-controlled Study	2009	63
The Influence of Vasoactive Agents on Metabolic Activity of the Liver in Cirrhosis: A Study of the Effects of Posterior Pituitary Extract, Vasopressin, and Somatostatin† Jean‐Claude Barbare, Raoul Poupon, Patrice Jaillon, Hepatology	1984	50

Page 1